GoodRx Holdings (GDRX) Current Assets (2019 - 2026)

GoodRx Holdings' Current Assets history runs 8 years deep, the most recent figure standing at $1.3 billion for Q1 2026.

• In Q1 2026, Current Assets rose 134.44% year-over-year to $1.3 billion; the TTM figure through Mar 2026 stood at $1.3 billion (up 134.44% YoY), while the FY2025 annual figure was $643.1 million, down 2.45% from the prior year.
• Current Assets came in at $1.3 billion for Q1 2026 at GoodRx Holdings, up from $643.1 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $1.3 billion in Q1 2026 to a low of $540.2 million in Q1 2025.
• A 5-year average of $805.3 million and a median of $872.8 million in 2023 frame the typical range for Current Assets.
• Across the five-year window, Current Assets sank 35.32% in 2024 and jumped 134.44% in 2026, its largest moves.
• GoodRx Holdings' Current Assets stood at $919.7 million in 2022, then fell by 5.1% to $872.8 million in 2023, then slipped by 24.47% to $659.3 million in 2024, then decreased by 2.45% to $643.1 million in 2025, then soared by 96.93% to $1.3 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $1.3 billion, $643.1 million, and $565.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison